Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Diabetic Macular Edema Market: Competitor Landscape
In May 2023, Oculis, a global pharmaceutical company prioritising eye care, revealed that their latest topical eye drop OCS-01, displayed positive results from stage 1 of phase 3 DIAMOND trial . The treatment provides an edge over current treatment alternatives of the disease, which mostly involve ocular implants or injections. It utilises Oculis' Optireach technology to deliver the effective medication to the retina. The rising prevalence for minimally invasive treatment alternatives has led to the development of relevant initiatives by industry leaders.
The key features of the diabetic macular edema market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- LEO Pharma
- Amneal Pharmaceuticals
- AstraZeneca
- Johnson & Johnson Private Limited
- Bausch Health Companies Inc.
- Eli Lilly and Company
- AbbVie Inc.
- Abbott
- F. Hoffmann-La Roche Ltd.
- Mylan N.V.
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
Diabetic Macular Edema Market Report Snapshots
Diabetic Macular Edema Market Size
Diabetic Macular Edema Market Regional Analysis
Diabetic Macular Edema Treatment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market attained a value of about USD 6.7 billion in 2023 driven by increasing incidence of diabetes across the 8 major markets.
The market is anticipated to grow at a CAGR of 5.1% during the forecast period of 2024-2032 and is likely to reach a market value of USD 10.4 billion by 2032.
The increasing research and development activities to discover a cure for condition, integration of technical advancements and prevalence for minimally invasive treatments are fuelling the market demand.
The surge in FDA approvals to facilitate improved solutions to the patients is a major market trend. In August 2023, FDA approved Regeneron’s EYLEA HD (aflibercept) Injection 8 mg for treating diabetic macular edema and related eye conditions. The approval was based on the results of 48-week PULSAR and PHOTON trials, wherein the drug candidate helped in significant vision gains in patients.
Based on disease type, the market is divided into focal diabetic macular edema and diffuse diabetic macular edema.
Hospitals fluorescein angiography, fundus imaging, and optical coherence tomography (OCT) among others are common diagnostic methods.
The route of administration can include intravitreal injections and implants.
The major regions of the market include the United States, EU-4, the United Kingdom, Japan and India.
Various types of treatments include oral iron therapy, parenteral iron therapy, and red blood cell transfusion.
Major distribution channels include hospital pharmacies, retail pharmacies, online pharmacies, and others.
End users in the market are hospitals, clinics, and home healthcare, among others.
Key players involved in the market are LEO Pharma, Amneal Pharmaceuticals, AstraZeneca, Johnson & Johnson Private Limited, Bausch Health Companies Inc., Eli Lilly and Company, AbbVie Inc., F. Hoffmann-La Roche Ltd., Mylan N.V., and Abbott.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
- Our Insights Store:
-
Industry Statistics
-
Procurement Insights
-
Consumer Insights
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124